Brazilian Society of Otology task force : Otosclerosis : evaluation and treatment

• Autor(a) principal: Silva, Vagner Antonio Rodrigues da
• Data de Publicação: 2023
• Outros Autores: Pauna, Henrique Furlan, Lavinsky, Joel, Guimarães, Guilherme Corrêa, Abrahão, Nicolau Moreira, Massuda, Eduardo Tanaka, Vianna, Melissa Ferreira, Ikino, Claudio Marcio Yudi, Santos, Vanessa Mazanek, Polanski, José Fernando, Silva, Maurício Noschang Lopes da, Sampaio, André Luiz Lopes, Zanini, Raul Vitor Rossi, Lourençone, Luiz Fernando Manzoni, Denaro, Mariana Moreira de Castro, Calil, Daniela Bortoloti, Chone, Carlos Takahiro, Castilho, Arthur Menino
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/265104
• topic: Otorrinolaringopatias; Otosclerose; Transtornos da audição; Perda auditiva; Auxiliares de audição; Hearing loss, conductive; Hearing loss, mixed conductive-sensorineural; Otosclerosis; Stapes surgery

Objectives: To review and provide evidence-based recommendations for the diagnosis and treatment of otosclerosis. Methods: Task force members were educated on knowledge synthesis methods, including electronic database search, review and selection of relevant citations, and critical appraisal of selected studies. Articles written in English or Portuguese on otosclerosis were eligible for inclusion. The American College of Physicians’ guideline grading system and the American Thyroid Association’s guideline criteria were used for critical appraisal of evidence and recommendations for therapeutic interventions. Results: The topics were divided into 2 parts: 1) Diagnosis- audiologic and radiologic; 2) Treatment- hearing AIDS, pharmacological therapy, stapes surgery, and implantable devices- bone-anchored devices, active middle ear implants, and Cochlear Implants (CI). Conclusions: The pathophysiology of otosclerosis has not yet been fully elucidated, but environmental factors and unidentified genes are likely to play a significant role in it. Women with otosclerosis are not at increased risk of worsening clinical condition due to the use of contraceptives or during pregnancy. Drug treatment has shown little benefit. If the patient does not want to undergo stapedotomy, the use of hearing aids is well indicated. Implantable systems should be indicated only in rare cases, and the CI should be indicated in cases of profound deafness.